METHOD FOR DETERMINING GENOTOXICITY

• US 20080138820A1
• Filed: 12/05/2007
• Published: 06/12/2008
• Est. Priority Date: 12/07/2006
• Status: Abandoned Application

• Current Assignee: GE Healthcare UK Limited (Danaher Corporation)
• Original Assignee: GE Healthcare UK Limited (Danaher Corporation)
• Inventors: THOMAS, NICHOLAS
• Application Number:
  US11/950,591
• Publication Number:
  US 20080138820A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12N 2510/00 Genetically modified cells
• CPC Class Codes: C12N 2830/002 inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
• CPC Class Codes: C12Q 1/6897 involving reporter genes operably linked to promoters
• CPC Class Codes: G01N 33/5014 for testing toxicity

Abstract

Disclosed are compositions and methods which provide an integrated approach to genotoxicity assessment procedures by employing a genetically engineered cell line to report on a number of key indicators of genotoxicity effects and mechanisms. Imaging and analysis of cells exposed to test agents allows automated analysis using high content cellular screening to identify cytostatic and/or cytotoxic activity, to quantify micronuclei formation, to discriminate aneugenic and clastogenic micronuclei and to detect DNA mutation and repair.

Claims

1. A cell comprising:

a) a first reporter gene construct comprising a nucleic acid molecule encoding a fluorescent protein fused to a centromere protein said nucleic acid sequence operably linked to and under the control of a promoter that is constitutively active; and

b) a second reporter gene construct comprising a nucleic acid molecule comprising one or more expression control sequences operably linked to a sequence encoding a nitroreductase (NTR) enzyme.

2. The cell of claim 1, wherein said centromere protein is centromere protein A (CENP-A).

3. The cell of claim 1, wherein said fluorescent protein is selected from Green Fluorescent Protein (GFP) or a functional GFP analogue.

4. The cell of claim 3, wherein said fluorescent protein is selected from wild type GFP, EGFP, EYFP, ECFP, F64L-GFP, BFP, NFP and Renilla GFP.

5. The cell of claim 1, wherein said expression control sequences comprise a DNA damage induced promoter.

6. The cell of claim 5, wherein said promoter is GADD45a.

7. The cell of claim 1, wherein the cell is a eukaryotic cell.

8. The cell of claim 7, wherein the cell is a mammalian cell.

9. A cell line comprising at least one cell engineered to:

a) constitutively express a fluorescent protein in fusion with a centromere protein; and

b) inducibly express a nitroreductase (NTR) enzyme reporter gene under the control of a DNA damage induced promoter.

10. The cell line of claim 9, wherein said centromere protein is centromere protein A (CENP-A).

11. The cell line of claim 9, wherein, said DNA damage induced promoter is GADD45a.

12. The cell line of claim 9, wherein the fluorescent protein is a Green Fluorescent Protein (GFP) or a functional GFP analogue.

13. The cell line of claim 12, wherein the fluorescent protein is selected from wild type GFP, EGFP, EYFP, ECFP, F64L-GFP, BFP, NFP and Renilla GFP.

14. The cell line of claim 9, wherein the cell is a mammalian cell.

15. A process for producing a cell line including at least one cell comprising first and second reporter gene constructs capable of being expressed, which process comprises:

a) transfecting one or more cells with a first and a second recombinant expression vector, wherein;

i) said first recombinant expression vector comprises a first reporter gene construct comprising a nucleic acid molecule encoding a fluorescent protein fused to a centromere protein said nucleic acid sequence operably linked to and under the control of a promoter that is constitutively active; and

ii) said second recombinant expression vector comprises a second reporter gene construct comprising a nucleic acid molecule comprising one or more expression control sequences operably linked to a sequence encoding a nitroreductase (NTR) enzyme; and

b) selecting transfected cells which express at least one and optionally both first and second reporter genes.

16. The process of claim 15, wherein said at least one cell is transfected with said first recombinant expression vector followed by said second recombinant expression vector.

17. A method for determining the effect of a test agent on a phenotypic property of a cell, which method comprises:

a) providing cells comprising;

i) a first reporter gene construct comprising a nucleic acid molecule encoding a fluorescent protein capable of emitting fluorescent light of a first wavelength (λ

₁) and being fused to a centromere protein said nucleic acid sequence operably linked to and under the control of a promoter that is constitutively active; and

ii) a second reporter gene construct comprising a nucleic acid molecule comprising one or more expression control sequences operably linked to a sequence encoding a nitroreductase (NTR) enzyme;

and wherein said cells are marked with a DNA staining dye that emits fluorescent light of a second wavelength (λ

₂) when bound to DNA;

b) contacting a population of said cells with;

iii) a test agent or a control; and

iv) a substrate for nitroreductase wherein said substrate is capable of emitting fluorescent light of a third wavelength (λ

₃);

under conditions permitting expression of said first and second reporter gene constructs; and

c) measuring the fluorescence intensity at different wavelengths of emitted light in said cell population;

wherein a difference in fluorescence intensity in cells treated with said test agent compared with cells treated with said control is indicative of the effect of said test agent on the phenotypic property of said cell.

18. The method of claim 17, wherein the fluorescent protein is a Green Fluorescent Protein (GFP) or a functional GFP analogue.

19. The method of claim 18, wherein the fluorescent protein is selected from wild type GFP, EGFP, EYFP, ECFP, F64L-GFP, BFP, NFP and Renilla GFP.

20. The method of claim 17, wherein said expression control sequences comprise a DNA damage induced promoter.

21. The method of claim 20, wherein said promoter is GADD45a.

22. The method of claim 17, wherein said nitroreductase substrate is a dye comprising at least one NO₂.

23. The method of claim 22, wherein said dye is a cyanine dye or a squaraine dye.

24. The method of claim 23, wherein said cyanine dye molecule is cell permeable.

25. The method of claim 22, wherein the dye has the formula:

26. The method of claim 25, wherein one of groups R¹ and R² is selected from group W where W is selected from:

27. The method of claim 25, wherein W is the group:

28. The method of claim 17, wherein the cell is a eukaryotic cell.

29. The method of claim 28, wherein the cell is a mammalian cell.

30. The method of claim 17, wherein said test agent is a chemical entity selected from a drug, a food dye, a hormone, a toxin, an alkylating agent, an oxidising agent, a carcinogen.

31. The method of claim 17, wherein said test agent is a physical agent selected from electromagnetic radiation (e.g. UV, X-ray, microwave), β

⁻

radiation, heat.

32. The method of claim 17, wherein said phenotypic property is selected to be cell number, nuclear morphology, micronuclear frequency, centromere status of micronuclei and reporter gene expression.

33. A diagnostic kit for identifying and characterising a toxic agent, said kit comprising:

a) at least one cell comprising;

i) a first reporter gene construct comprising a nucleic acid molecule encoding a fluorescent protein fused to a centromere protein said nucleic acid sequence operably linked to and under the control of a promoter that is constitutively active; and

ii) a second reporter gene construct comprising a nucleic acid molecule comprising one or more expression control sequences operably linked to a sequence encoding a nitroreductase (NTR) enzyme; and

b) a nitroreductase (NTR) enzyme substrate.